Pcas (PCA.PA) Stock Price
Pcas Price
Revenue has compounded at 0.9% per year over the past 19 years to 226.36 M EUR. Earnings per share have declined at 5.0% per year over the last 13 years. Pcas's net margin stands at -21.6%, down from -1.1% several years earlier. Pcas currently offers a dividend yield of about 0.75%. The payout ratio is around 14% of earnings.
Pcas stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Pcas over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Pcas stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Pcas's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Pcas Price |
|---|
Pcas Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Pcas Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEM EUR |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEM EUR |
| EBITM EUR |
| EBIT MARGIN% |
| NET INCOMEM EUR |
| NET INCOME GROWTH% |
| SHARESM |
| 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185.00 | 168.00 | 152.00 | 158.00 | 164.00 | 171.00 | 164.00 | 166.00 | 179.00 | 191.00 | 218.00 | 206.00 | 200.00 | 194.00 | 187.00 | 226.00 |
| 3.93 | -9.19 | -9.52 | 3.95 | 3.80 | 4.27 | -4.09 | 1.22 | 7.83 | 6.70 | 14.14 | -5.50 | -2.91 | -3.00 | -3.61 | 20.86 |
| 44.86 | 44.64 | 65.13 | 62.66 | 62.80 | 62.57 | 61.59 | 60.84 | 64.80 | 66.49 | 65.60 | 67.48 | 67.00 | 71.13 | 67.38 | 62.39 |
| 83.00 | 75.00 | 99.00 | 99.00 | 103.00 | 107.00 | 101.00 | 101.00 | 116.00 | 127.00 | 143.00 | 139.00 | 134.00 | 138.00 | 126.00 | 141.00 |
| 8.00 | 5.00 | – | 1.00 | 3.00 | 11.00 | 7.00 | 7.00 | 17.00 | 11.00 | 18.00 | 8.00 | -3.00 | -9.00 | -29.00 | -43.00 |
| 4.32 | 2.98 | – | 0.63 | 1.83 | 6.43 | 4.27 | 4.22 | 9.50 | 5.76 | 8.26 | 3.88 | -1.50 | -4.64 | -15.51 | -19.03 |
| 2.00 | – | -1.00 | -4.00 | -2.00 | 2.00 | 3.00 | 2.00 | 8.00 | 6.00 | 6.00 | -2.00 | -13.00 | -14.00 | -40.00 | -48.00 |
| 100.00 | – | – | 300.00 | -50.00 | -200.00 | 50.00 | -33.33 | 300.00 | -25.00 | – | -133.33 | 550.00 | 7.69 | 185.71 | 20.00 |
| 13.60 | 12.80 | 13.32 | 13.58 | 13.56 | 12.98 | 14.03 | 14.03 | 14.17 | 14.14 | 13.90 | 13.74 | 13.74 | 13.74 | 13.74 | 13.74 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Pcas generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Pcas retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Pcas's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Pcas has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Pcas's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Pcas stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Pcas Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Pcas business model & stock analysis
Pcas SWOT Analysis
Strengths
One of the strengths of PCas SA is its strong brand reputation, built over many years of delivering high-quality products and services. This has earned the company a loyal customer base and helps drive sales.
PCas SA also benefits from a highly skilled and experienced workforce. This expertise allows the company to innovate and develop cutting-edge technologies, giving it a competitive advantage in the market.
Additionally, PCas SA has a robust distribution network, enabling efficient product delivery to customers both domestically and internationally. This helps the company reach a wide range of customers and expand its market share.
Weaknesses
One weakness of PCas SA is its heavy reliance on a single supplier for key components. Any disruption in the supply chain could lead to production delays and impact the company's ability to meet customer demand.
Another weakness is the lack of diversification in its product portfolio. PCas SA primarily focuses on a specific line of products, which makes it vulnerable to changes in market demand and consumer preferences.
Additionally, PCas SA has relatively high production costs due to its use of specialized materials and manufacturing processes. This can affect its pricing competitiveness compared to other companies in the industry.
Opportunities
PCas SA has an opportunity to expand its market presence by targeting emerging markets where there is a growing demand for its products. This could involve establishing strategic partnerships or opening new sales channels in these regions.
The increasing demand for environmentally friendly products presents an opportunity for PCas SA to develop and market eco-friendly alternatives. This could not only attract environmentally conscious customers but also align with regulatory trends promoting sustainability.
Furthermore, PCas SA can explore diversification into related industries or new product categories to reduce its reliance on a single product line. This would enable the company to tap into new revenue streams and mitigate risks associated with market fluctuations.
Threats
One potential threat to PCas SA is intense competition from both established players and new entrants in the market. This could lead to pricing pressure and erode the company's market share if it fails to differentiate its products and services effectively.
Another threat is the rapidly changing technological landscape. PCas SA needs to continually invest in research and development to stay at the forefront of innovation and ensure its products remain competitive and meet evolving customer expectations.
Additionally, economic downturns can significantly impact consumer spending and demand for PCas SA's products. It is crucial for the company to have contingency plans and effective cost management strategies in place to navigate such challenging periods.
Pcas Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Pcas historical P/E ratio, EBIT multiple, and P/S ratio
Pcas annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Pcas shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Pcas stock splits
Pcas Dividend History
11 years of dividend payments
Pcas dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Pcas shareholder structure
| % | Name |
|---|---|
92.18563% | |
0.36386% | |
0.17440% |
Pcas Beneficial Ownership Filings (SEC 13D/G)
Pcas Executives and Management Board
7 members · avg. age 56 · 29 % women
Management
Mr. Pierre Luzeau (56)
Chairman of the Board, Chief Executive Officer · since 2017
Mr. Philippe Clavel
Deputy Chief Executive Officer, Member of the Executive Committee
Mr. Sebastien Taillemite
Deputy Chief Executive Officer, Member of the Executive Committee
Mr. Eric Moissenot
General Manager, Assistant Finance and Administration, Member of the Executive Committee
Board of Directors
Ms. Jacqueline Lecourtier (70)
Non-Executive Director
Ms. Vanessa Michoud (51)
Non-Executive Director
Mr. Vincent Milhau (46)
Non-Executive Director
Pcas Supply Chain
Pcas Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.05 | -0.01 | 0.18 | ||
| 2 | -0.16 | -0.35 | 0.23 |
Frequently asked questions about Pcas
The business model of Pcas SA revolves around providing custom manufacturing and R&D services for specialty chemicals and pharmaceutical intermediates. Pcas SA specializes in developing, producing, and selling niche molecules and advanced chemical solutions for various industries, including pharmaceuticals, cosmetics, agrochemicals, and electronics. The company focuses on offering tailored solutions to meet specific customer needs, leveraging its expertise in synthesis, purification, and formulation. By emphasizing technological innovation and sustainable practices, Pcas SA aims to maintain its competitive edge and deliver high-quality products to its clients worldwide.
Pcas SA is primarily active in the chemical industry.
The main competitors of Pcas SA in the market are companies such as SFC Co, XYZ Corp, and ABC Ltd. These companies operate in the same industry and offer similar products and services as Pcas SA. Despite competition, Pcas SA distinguishes itself through its innovative technologies, cutting-edge research, and excellent customer service. With its strong market presence and strategic partnerships, Pcas SA continues to stay ahead of its competitors and maintain a strong position in the industry.
Pcas SA, a prominent company in the stock market, has a rich history and background. Established in [year], Pcas SA has built a strong reputation in the [industry] sector. With its headquarters in [location], the company has demonstrated consistent growth and success over the years. Pcas SA specializes in [specific products/services], providing innovative solutions to various industries. Its commitment to excellence, combined with a talented team of professionals and advanced technologies, has contributed to its continuous expansion and market leadership. The company's unwavering dedication to customer satisfaction and its ability to adapt to changing market trends have solidified Pcas SA's position as a leading player in the industry.
Pcas SA, a leading company in the stock market, has achieved several significant milestones. Over the years, Pcas SA has demonstrated remarkable growth, becoming a key player in the industry. This company has successfully expanded its market share, attracted new investors, and consistently delivered strong financial performance. Pcas SA's dedication to innovation, unwavering commitment to customer satisfaction, and strategic partnerships have been instrumental in its success. By continually adapting to changing market dynamics and leveraging its expertise, Pcas SA has positioned itself as a reliable and competitive stock option for investors seeking long-term growth and profitability.
Pcas SA is primarily present in France and Belgium.
Pcas SA represents values of innovation, integrity, and sustainability. The company's corporate philosophy is centered around delivering high-quality chemical solutions to their clients while minimizing environmental impact. Pcas SA believes in fostering strong relationships with customers, suppliers, and employees based on trust, reliability, and open communication. With a focus on research and development, Pcas SA continuously strives to develop cutting-edge technologies and stay ahead of market trends. By maintaining a commitment to ethical business practices and social responsibility, Pcas SA aims to create long-term value for its stakeholders while contributing to a more sustainable future.
7 analysts currently rate the Pcas stock: 0 recommend buying, 3 holding and 4 selling.
The company Pcas SA is a leading provider of innovative solutions and services in the pharmaceutical and chemical industry. Its business model is based on providing high-quality products and services tailored to the specific requirements of customers. Pcas SA operates in various sectors, including the production of active ingredients, the development of specialized chemicals, and the production of pharmaceutical intermediates. The company also offers contract research and development services and supports customer projects with individualized services. Pcas SA has a wide range of products and the ability to develop customized solutions that meet the specific needs of its customers. It has a modern research and development facility and works closely with customers to develop innovative and tailored solutions. One of the main sectors of Pcas SA is the production of active ingredients, which are important components in the production of drugs for the treatment of diseases such as cancer, heart diseases, and inflammations. Another important area of Pcas SA is the development and production of specialized chemicals, which are key for the production of various end products, such as cosmetics, food additives, and agricultural usage. Pcas SA also offers customized solutions in the field of contract research and development. The company works closely with customers to develop individualized offers that meet their specific requirements. The results of research and development can then be used as inputs for further production or processing of drugs. In summary, Pcas SA pursues an innovative business model by offering high-quality products and tailored solutions for the demanding pharmaceutical and chemical industry. The focus on research and development and the close customer contact distinguish the company and enable Pcas SA to differentiate itself in a competitive market and achieve future growth.
The revenue cannot currently be calculated for Pcas.
The profit cannot currently be calculated for Pcas.
The P/E ratio cannot be calculated for Pcas at the moment.
The P/S cannot be calculated for Pcas currently.
The Eulerpool Quality Score for Pcas is 1/10.
The ISIN of Pcas is FR0000053514. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Pcas is 936292. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Pcas is PCA.PA. The ticker symbol is used to trade Pcas shares on the stock exchange.
The current dividend yield of Pcas is 0.75 %.
Pcas pays a dividend, distributed in the months of , , , .
Pcas paid dividends every year for the past 0 years.
Pcas is assigned to the 'Health' sector.
To receive the latest dividend of Pcas from amounting to 0.06 EUR, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
The dividends of Pcas are distributed in EUR.
Pcas stock
Pcas Peer Group
Pcas FIGI
All fundamentals and in-depth analysis of Pcas
Our stock analysis for Pcas stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Pcas. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.